Overview

A Study of MK0594 in Patients With Alcohol Dependence (0594-020)

Status:
Terminated
Trial end date:
2010-03-11
Target enrollment:
Participant gender:
Summary
A study in patients with alcohol dependence to see if MK0594 is safe and effective in maintaining absence of heavy drinking over a 12-week treatment period.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Vyne Therapeutics Inc.